IREN's newly signed multiyear deal with Anthropic should drive a big pop in the stock within 15 minutes. x.comÂ
Heisenberg
Stock Chartist, Long/Short Ideas
IREN's reported multi-year deal with Anthropic brings bullish news as the stock tests support, per Mr. Derivatives. x.comÂ
IREN holders could see insane upside when Anthropic goes public soon after its reported multiyear cloud deal with IREN. Per The Information, Anthropic signed a cloud deal with IREN; the stock rose over 7% on the partnership report. x.comÂ
IREN's predatory management and markedly weaker execution than Nebius make it hard to take seriously while Mike Alfred remains on its board. Barring an oversold bounce, IREN looks cooked big time with more time. x.com x.comÂ
An Anthropic deal adds a catalyst to the bullish case for IREN. A double smart-money zone on the chart also underpins the 'send it' call. x.comÂ
IREN's deal economics, not the Anthropic name alone, will determine whether locked-in demand earns good returns. The reported deal is good news, but its terms remain unknown, and a buyer that large can negotiate hard on price. IREN should do well: it still has more capacity to sell and is expected to charge a premium for it. x.comÂ
IREN's reported Anthropic cloud deal is unlikely to sustain a stock pop because investors look past the brand halo to capex and dilution. Every stock with an Anthropic announcement gave back its gains, and neocloud compute deals do not seem to be driving re-ratings lately, regardless of terms. x.com x.com x.comÂ
IREN's long-term appeal rests on its standing as one of the best vertically integrated AI neoclouds. In the short term, the stock has not been this oversold since 2022. x.comÂ
A reportedly signed multi-year Anthropic cloud agreement could take IREN into the $50s sooner than the prior January 2027 expectation. The agreement is unannounced, and the report may be unverified, but the long view remains. x.com x.comÂ
IREN's spending and ongoing financing still weigh on its shares despite a signed Anthropic deal. Its 2027 capex is put at $25-30B and its $6B ATM appears roughly halfway complete. Mirantis has improved fundamentals, but markets likely care more in about six months as revenue approaches and the ATM/capex window passes, as with Nebius after its Meta deal. A risk-off rotation to larger names adds pressure. x.comÂ
IREN's $8 billion in cash against a valuation of just $10 billion points to unfathomable upside potential. Its shares are back below their $28 IPO price. x.comÂ